Oncura signs distribution agreement with Theragenics for palladium-103 brachytherapy seeds
Links shared publicly online about this topic.
- 1,022total visits
Oncura signs distribution agreement with Theragenics for palladium-103 brachytherapy seeds
View full resource at news-medical.net
Tags: Cancer, Lung Cancer, Prostate Cancer, Lung, Prostate, Healthcare, Men's Health
Most Recently Shared on July 14, 2010 at 6:05 pm By:
Prostate Cancer: Oncura signs distribution agreement with Theragenics for palladium-103 brachytherapy seeds: ONCUR... http://bit.ly/bzj9Bl
Also Shared By:
Theragenics signs supply agreement with Oncura for TheraSeed palladium-103 brachytherapy seeds
news-medical.net — “Theragenics Corporation, a medical device company serving the surgical products and prostate cancer treatment markets, today announced that it has signed an agreement with Oncura, Inc. for the distribution of TheraSeed® palladium-103 brachytherapy seeds. Oncura is a unit of GE Healthcare. Under the terms of the agreement, Theragenics will be the exclusive palladium-103 seed supplier to Oncura, subject to certain pre-existing vendor agreements, for the treatment of prostate cancer in the U.S” View full resource at news-medical.net
Most Recently Shared on July 12, 2010 at 1:08 pm By:
Theragenics signs supply agreement with Oncura for TheraSeed palladium-103 brachytherapy seeds: Theragenics Corpor... http://bit.ly/cf3oCP
Advertisement
News-Medical.Net
@Lung_Cancer_
Lung Cancer News: Oncura signs distribution agreement with Theragenics for palladium-103 brachytherapy seeds: ONCU... http://bit.ly/bzj9Bl
1 year ago...